Consistently, in real-time in vivo imaging studies, vascular Aβ clearance is carried out by patrolling monocytes (36), according to previous results showing that peripherally derived myeloid cells are protective in AD through mechanisms of brain recruitment involving MCP-1 chemotaxis (37–39). Here, CCL2 is linked to Alzheimer disease.